MDManan Desai

Manan Desai

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Manan Desai has a total of 134 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Relationship Between Timing of Surgery and Procedure-Specific Outcomes in Neonates and Infants for Congenital Heart Surgery.

    by Syed Muhammad Ali Bukhari, Rittal Mehta, Muhammed Ikbal Aydin, Mitchell C. Haverty, Manan Desai, Aybala Tongut, Bao N. Puente, Wayne J. Franklin, Can Yerebakan, Yves D’UDekem

  • Open Access

    Outcomes of Delayed Norwood Operation in High-Risk Patients—Time to Reconsider the Dogma of a Primary Norwood Operation?

    by Mahmut Ozturk, Arif Selcuk, Aybala Tongut, Elizabeth M Moynihan, Manan Desai, Alejandro Jose Lopez Magallon, Mary T Donofrio, Heather Gordish-Dressman, Kathleen Kalinger Reid, Ricardo Alfonso Munoz, et al.

    Objectives: The delayed Norwood (DN) approach, preceded by bilateral pulmonary artery banding (bPAB), has emerged as a strategy to improve outcomes in high-risk infants by addressing neonatal haemodynamic instability and organ immaturity. Methods: This single-centre, retrospective study analysed 20 consecutive patients with hypoplastic left heart syndrome/variants and multiple risk factors who underwent a DN operation following bPAB between 2019 and 2024. Results: Bilateral pulmonary artery banding was performed at a median age of 2.5 days (interquartile range [IQR]: 2-4). Preoperative risk factors included prematurity (35%), low birth weight <2.5 kg (25%), non-cardiac comorbidities (25%), genetic syndromes (50%), preoperative cardiogenic shock (35%), and restrictive atrial septum (25%). The median age at DN was 36 days (IQR: 29-79), with an operative survival rate of 75%. Patients who underwent the DN within 4 weeks of bPAB did not require any pulmonary artery (PA) reinterventions. Median lactate clearance time was 8 hours (IQR: 5-18), and the median vasoactive inotropic score decreased by 47% within 48 hours postoperatively. Cerebral near-infrared spectroscopy values improved in patients without postoperative extracorporeal membrane oxygenation (ECMO) support from 53% to 58% and 63% at 0, 12, and 36 hours, respectively. Conclusions: The DN approach, preceded by initial bPAB in a high-risk patient cohort, achieved surgical outcomes comparable to those of lower-risk patients undergoing primary Norwood operation. A DN procedure around 4-6 weeks of following bPAB may improve survival rates in high-risk patients with a reduction in surgical or catheter-based reinterventions.

  • Open Access

    Neonatal primary repair of pulmonary atresia with ventricular septal defect without major aortopulmonary collateral arteries: midterm outcomes

    by Aybala Tongut, Irmak Yıldız, Mitchell C Haverty, Alix Fetch, Can Yerebakan, Bao N Puente, Joshua P Kanter, Yves D’UDekem, Manan Desai

    OBJECTIVES: Pulmonary atresia with ventricular septal defect (PA-VSD) without major aortopulmonary collateral arteries is a rare congenital heart defect. Surgical management strategies include staged palliation or primary neonatal repair. We evaluated the midterm outcomes of neonatal primary repair in patients without MAPCAs. METHODS: A retrospective single-center analysis was performed of 31 neonates who underwent primary repair for PA-VSD without MAPCAs between 2005 and 2024. Primary outcomes included mortality, reintervention rates, and right ventricular (RV) function. RESULTS: Thirteen patients (41.9%) underwent urgent surgery and 18 (58.1%) underwent emergent surgery. Median weight at repair was 2.8 kg (interquartile range [IQR] 2.6–3.2). Overall survival was 96.8% (n = 30), with one mortality (3.2%) related to multi-organ failure. Postoperative RV function was normal in 25 patients (80.7%). Median follow-up for hospital survivors was 5.4 years (IQR 1.2–7.6). Freedom from surgical reoperation was 56.7%; 13 patients (43.3%) required reoperation, most commonly for RV-to-pulmonary artery conduit revision (n = 11). Catheter-based reinterventions were performed in 24 patients (80.0%). RV function remained preserved in 29 patients (96.7%) at last follow-up. CONCLUSIONS: Neonatal primary repair of PA-VSD without major aortopulmonary collaterals can be performed with excellent midterm survival and preserved right ventricular function. Reintervention, largely conduit-related, represents an anticipated component of longitudinal management rather than failure of the primary strategy.

  • Open Access

    Comparing Outcomes of Heartmate 3 and Heart Transplantation in Older Children With Dilated Cardiomyopathy—Can Transplantation be Delayed or Avoided?

    by Waldemar F. Carlo, Luz A. Padilla, James K. Kirklin, Ryan S. Cantor, Devin Koehl, Jeffrey P. Jacobs, Shahnawaz Amdani, Kathryn Chatfield, Manan Desai, Gabrielle Vaughn, et al.

    Background: Children with end‐stage dilated cardiomyopathy (DCM) usually undergo heart transplantation or a short‐term bridge with a ventricular assist device. Heartmate 3 (HM3) may represent an appealing longer‐term option, though pediatric data are limited. We analyzed two clinical registries and hypothesized that adolescents with DCM treated with either HM3 or transplant would present similar survival. Methods: The Pedimacs and Pediatric Heart Transplant Society registries were queried for DCM patients ages 10–18 years treated with HM3 or transplant, between 2017 and 2022. Mortality and adverse events were reported. Results: Ninety HM3 and 306 transplant patients were reported within the respective registries. There was a higher proportion of Black patients in the HM3 cohort (40% vs. 30% in the transplant cohort, p = 0.03). Twelve‐ and 36‐month survival rates were both 94.4% for HM3 patients and were 99.3% and 95.6% for transplant patients. In the HM3 group, there were 66 transplants (median time of 2.8 months), 3 late explants for recovery, and 3 early deaths. Conditional 1‐year survival for HM3 and transplant was 100% and 96.3%, respectively, at 3 years. In the HM3 group, bleeding, stroke, and device malfunction rates were low at 0.1 events per patient per year. Conclusions: Adolescents with DCM treated with either HM3 or transplant had excellent 3‐year outcomes, though many HM3 pediatric patients are transplanted early after device placement. Safely supporting this group of patients for an extended duration with HM3 has implications for delaying/avoiding transplantation, longer‐term patient survival, and donor organ availability.


  • Open Access

    Injection Laryngoplasty as a Means of Resolving Symptomatic Vocal Cord Immobility After Congenital Heart Surgery

    by Mitchell C Haverty, Courtney Long, Alyssia Venna, Manan Desai, Aybala Tongut, Bao N Puente, Yves D’UDekem, Pamela Mudd

    Objectives: Vocal cord immobility immediately following cardiac surgery is associated with reduced airway protection, dysphagia and aspiration in infant and paediatric populations. Early vocal medialization shows promise in optimizing feeding outcomes and swallowing mechanics. We aim to demonstrate the outcomes of injection laryngoplasty in patients with symptomatic vocal cord immobility after paediatric cardiac surgery. Methods: Data from cardiac surgery patients who underwent injection laryngoplasty between January 2021 and December 2024 at a single-centre institution were reviewed. Data was analysed following the implementation of a vocal cord injury protocol, including laryngeal ultrasound screening, preoperative dysphagia assessment, injection laryngoplasty and postoperative dysphagia evaluation as medically appropriate. Results: Thirty-one patients underwent injection laryngoplasty after diagnosis of symptomatic unilateral vocal cord immobility with objectively identified dysphagia a median of 10 days (2-63) after surgery. A postoperative endoscopic or fluoroscopic swallow study was conducted with dysphagia improving or resolving in 26 of 31 patients post-injection. Four patients were discharged with gastrostomy tubes. Seven patients had a documented complication, including stridor, escalation of care setting, and additional required procedures. These were short-lived and often associated with underlying congenital heart disease and unrelated to vocal cord injection. Conclusions: Injection laryngoplasty as an intervention for vocal immobility and dysphagia following cardiovascular surgery is a low-risk procedure, allowing safer advancement of oral diet in most patients prior to discharge. We postulate it also improves dysphagia in the subacute phase and may lead to longer-term benefit in glottic protection.

  • Open Access

    Is the patch repair of partial anomalous pulmonary venous drainage equivalent to the Warden procedure?

    by Aybala Tongut, Zeynep Bengi Eren, Mahmut Öztürk, Manan Desai, Micheal David Tsifansky, Yves D’udekem, Can Yerebakan

    Introduction: Partial anomalous pulmonary venous return (PAPVR) is a congenital heart defect frequently associated with a sinus venosus atrial septal defect (ASD). Surgical repair varies depending on the anatomical position of the anomalous pulmonary veins. This study aims to compare the outcomes of three surgical techniques - single patch, two-patch technique, and Warden procedure- used in the repair of PAPVR with sinus venosus ASD. Methods: A retrospective study was conducted, analyzing the outcomes of 87 patients who underwent surgical repair for PAPVR between January 2011 and August 2024. Patients were divided into three groups based on the surgical technique used: 44 underwent the Warden procedure, 33 were treated with the single-patch technique, and 10 received the two-patch technique. Results: No mortality was observed across all techniques. The median age at operation was 5.4 years (1.4–10.4 years), and the median hospital stay was 3.0 days (IQR 3.0–4.0). Logistic regression analysis revealed a higher likelihood of immediate postoperative complications with the Warden technique (OR: 5.00, 95% CI [1.30–19.25], p = 0.0193). No patients required a pacemaker implantation. Four patients who had a single (2) and double patch (2) technique needed a reintervention on the systemic or pulmonary venous pathway, while no patient who had a Warden procedure needed a reintervention of the venous pathways. Conclusion: Despite a higher risk of early complications, the Warden procedure seems to preserve patients from reinterventions on the systemic or pulmonary venous pathway.

  • The single ventricle presenting late: surgical options

    by Sachin Talwar, Supreet Marathe, Manan Desai, Navnita Kisku, Vishal Vinayak Bhende

    The term single ventricle (SV) comprises a wide variety of congenital anomalies with a structurally or functionally univentricular heart where a biventricular repair is not possible or undesirable. The surgical management of these patients is often staged and the ultimate palliation is the Fontan operation (FO). Despite advances in surgical techniques, significant challenges persist in the management of SV patients, particularly in low- and middle-income countries (LMICs), where delayed presentation and limited healthcare access are common. This review explores current management strategies for patients beyond childhood, including those who have never undergone palliation and post-Fontan patients facing long-term complications. Key topics include the surgical approaches to SV, such as pulmonary artery banding (PAB), bidirectional Glenn (BDG), and FO, with particular focus on considerations for late-presenting adults in LMICs. The disparities in healthcare resources between high-income countries and LMICs are highlighted, demonstrating that resource constraints significantly impact timely interventions and on-going follow-up care.

  • Rehabilitation Strategy Should Not Be a Pretext for Suboptimal Repair for Pulmonary Atresia, Ventricular Septal Defect, and Major Aortopulmonary Collateral Arteries

    by Manan H. Desai, Aybala Tongut, Yves D’uDekem

    Pulmonary atresia, ventricular septal defect, and major aortopulmonary collaterals are a challenging congenital anomaly to manage surgically with different centers and strategies producing wide-ranging outcomes. Over the past few decades despite diverging treatment pathways, there is an emerging consensus of how these patients “should” be treated. Quite often a combination of rehabilitation strategy and a unifocalization approach has to be tailored to each patient to address the anatomic and physiological variations that characterize this congenital heart defect. Irrespective of the surgical approach, the goal should be to have a complete repair with acceptable right heart pressure ensuring survival and a good quality of life.


  • Real-Time Detection of Circulating Thrombi in an Extracorporeal Circuit Using Doppler Ultrasound: In-Vitro Proof of Concept Study

    by Syed Murfad Peer, Manan Desai, Syed Bukhari, Yunchuan Delores, Richard Jonas, Pranava Sinha

    Background: Thromboembolic stroke continues to be by far the most common severe adverse event in patients supported with mechanical circulatory assist devices. Feasibility of using Doppler ultrasound to detect circulating thrombi in an extracorporeal circuit was investigated. Methods: A mock extracorporeal circulatory loop of uncoated cardiopulmonary bypass tubing and a roller pump was setup. A Doppler bubble counter was used to monitor the mean ultrasound backscatter signal (MUBS). The study involved two sets of experiments. In Scenario 1, the circuit was sequentially primed with human blood components, and the MUBS was measured. In Scenario 2, the circuit was primed with heparinized fresh porcine blood, and the MUBS was measured. Fresh blood clots (diameter 5,000 microns) were injected into the circuit followed by protamine administration. Results: In Scenario 1 (n = 3), human platelets produced a baseline MUBS of 1.5 to 3.5 volts/s. Addition of packed human red blood cells increased the baseline backscatter to 17 to 21 volts/s. Addition of fresh frozen plasma did not change the baseline backscatter. In Scenario 2 (n = 5), the blood-primed circuit produced a steady baseline MUBS. Injection of the clots resulted in abrupt and transient increase (range: 3-30 volts/s) of the baseline MUBS. Protamine administration resulted in a sustained increase of MUBS followed by circuit thrombosis. Conclusions: Doppler ultrasound may be used for real-time detection of circulating solid microemboli in the extracorporeal circuit. This technology could potentially be used to design safety systems that can reduce the risk of thromboembolic stroke associated with mechanical circulatory support therapy.